Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article
- Language: English
- [Inflammation] 2024 Apr; Vol. 47 (2), pp. 609-625. <i>Date of Electronic Publication: </i>2024 Mar 07.
- MeSH Terms: Diet, High-Fat* / adverse effects ; Sialic Acid Binding Immunoglobulin-like Lectins* / metabolism ; Inflammation* / metabolism ; Erythrocytes* / metabolism ; Erythrocytes* / drug effects ; Glucose* / metabolism ; Antigens, Differentiation, B-Lymphocyte* ; Animals ; Mice ; Ligands ; Atherosclerosis / metabolism ; Atherosclerosis / prevention & control ; Antigens, CD / metabolism ; Dietary Supplements ; Male ; Mice, Inbred C57BL
- References: Kolaczkowska, E., and P. Kubes. 2013. Neutrophil recruitment and function in health and inflammation. Nature Reviews Immunology 13: 159–175. https://doi.org/10.1038/nri3399 . (PMID: 10.1038/nri339923435331) ; Zhou, M.G., H.D. Wang, X.Y. Zeng, P. Yin, J. Zhu, W.Q. Chen, X.H. Li, L.J. Wang, L.M. Wang, Y.N. Liu, J.M. Liu, M. Zhang, J.L. Qi, S.C. Yu, A. Afshin, E. Gakidou, S. Glenn, V.S. Krish, M.K. Miller-Petrie, et al. 2019. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: A systematic analysis for the global burden of disease study 2017. Lancet 394: 1145–1158. https://doi.org/10.1016/S0140-6736(19)30427-1 . (PMID: 10.1016/S0140-6736(19)30427-1312486666891889) ; Soehnlein, O. 2012. Multiple roles for neutrophils in atherosclerosis. Circulation Research 110: 875–888. https://doi.org/10.1161/CIRCRESAHA.111.257535 . (PMID: 10.1161/CIRCRESAHA.111.25753522427325) ; Swirski, F.K., M.J. Pittet, M.F. Kircher, E. Aikawa, F.A. Jaffer, P. Libby, and R. Weissleder. 2006. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proceedings of the National Academy of Sciences 103: 10340–10345. https://doi.org/10.1073/pnas.0604260103 . (PMID: 10.1073/pnas.0604260103) ; Tabas, I., and A.H. Lichtman. 2017. Monocyte-macrophages and T cells in atherosclerosis. Immunity 47: 621–634. https://doi.org/10.1016/j.immuni.2017.09.008 . (PMID: 10.1016/j.immuni.2017.09.008290458975747297) ; Duewell, P., H. Kono, K.J. Rayner, C.M. Sirois, G. Vladimer, F.G. Bauernfeind, G.S. Abela, L. Franchi, G. Nuñez, M. Schnurr, T. Espevik, E. Lien, K.A. Fitzgerald, K.L. Rock, K.J. Moore, S.D. Wright, V. Hornung, and E. Latz. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357–1361. https://doi.org/10.1038/nature08938 . (PMID: 10.1038/nature08938204281722946640) ; DiRenzo, D., G.K. Owens, and N.J. Leeper. 2017. “Attack of the clones”: Commonalities between cancer and atherosclerosis. Circulation Research 120: 624–626. https://doi.org/10.1161/CIRCRESAHA.116.310091 . (PMID: 10.1161/CIRCRESAHA.116.310091282097945822423) ; Fredman, G., and I. Tabas. 2017. Boosting inflammation resolution in atherosclerosis: The next frontier for therapy. The American Journal of Pathology 187: 1211–1221. https://doi.org/10.1016/j.ajpath.2017.01.018 . (PMID: 10.1016/j.ajpath.2017.01.018285277095455064) ; Libby, P. 2017. Interleukin-1 beta as a target for atherosclerosis therapy: Biological basis of CANTOS and beyond. Journal of the American College of Cardiology 70: 2278–2289. https://doi.org/10.1016/j.jacc.2017.09.028 . (PMID: 10.1016/j.jacc.2017.09.028290739575687846) ; Zhang, J.Q., G. Nicoll, C. Jones, and P.R. Crocker. 2000. Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes. The Journal of Biological Chemistry 275: 22121–22126. https://doi.org/10.1074/jbc.M002788200 . (PMID: 10.1074/jbc.M00278820010801862) ; Yu, Z., M. Maoui, L. Wu, D. Banville, and S. Shen. 2001. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2. The Biochemical Journal 353: 483–492. https://doi.org/10.1042/0264-6021:3530483 . (PMID: 10.1042/0264-6021:3530483111710441221593) ; Lizcano, A., I. Secundino, S. Döhrmann, R. Corriden, C. Rohena, S. Diaz, P. Ghosh, L.Q. Deng, V. Nizet, and A. Varki. 2017. Erythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation. Blood 129: 3100–3110. https://doi.org/10.1182/blood-2016-11-751636 . (PMID: 10.1182/blood-2016-11-751636284165105465837) ; Liu, H.M., Y. Zheng, Y.X. Zhang, J. Li, S.M. Fernandes, D.F. Zeng, X.H. Li, R.L. Schnaar, and Y. Jia. 2020. Immunosuppressive Siglec-E ligands on mouse aorta are up-regulated by LPS via NF-κB pathway. Biomedicine & Pharmacotherapy 122: 109760. https://doi.org/10.1016/j.biopha.2019.109760 . (PMID: 10.1016/j.biopha.2019.109760) ; Zhang, Y.X., Y. Zheng, J. Li, L. Nie, Y.J. Hu, F.J. Wang, H.M. Liu, S.M. Fernandes, Q.J. Zhong, X.H. Li, R.L. Schnaar, and Y. Jia. 2019. Immunoregulatory Siglec ligands are abundant in human and mouse aorta and are up-regulated by high glucose. Life Sciences 216: 189–199. https://doi.org/10.1016/j.lfs.2018.11.049 . (PMID: 10.1016/j.lfs.2018.11.04930471282) ; Citro, A., A. Valle, E. Cantarelli, A. Mercalli, S. Pellegrin, D. Liberati, L. Daffonchio, O. Kastsiuchenka, P.A. Ruffini, M. Battaglia, M. Allegretti, and L. Piemonti. 2015. CXCR1/2 inhibition blocks and reverses type 1 diabetes in mice. Diabetes 64: 1329–1340. https://doi.org/10.2337/db14-0443 . (PMID: 10.2337/db14-044325315007) ; Gautier, E.F., M. Leduc, S. Cochet, K. Bailly, C. Lacombe, N. Mohandas, F. Guillonneau, W.E. Nemer, and P. Mayeux. 2018. Absolute proteome quantification of highly purified populations of circulating reticulocytes and mature erythrocytes. Blood Advances 2: 2646–2657. https://doi.org/10.1182/bloodadvances.2018023515 . (PMID: 10.1182/bloodadvances.2018023515303273736199659) ; Nakajima, K., S. Kitazume, T. Angata, R. Fujinawa, K. Ohtsubo, E. Miyoshi, and N. Taniguchi. 2010. Simultaneous determination of nucleotide sugars with ion-pair reversed-phase HPLC. Glycobiology 20: 865–871. https://doi.org/10.1093/glycob/cwq044 . (PMID: 10.1093/glycob/cwq04420371511) ; Kochanowski, N., F. Blanchard, R. Cacan, F. Chirat, E. Guedon, A. Marc, and J.L. Goergen. 2006. Intracellular nucleotide and nucleotide sugar contents of cultured CHO cells determined by a fast, sensitive, and high-resolution ion-pair RP-HPLC. Analytical Biochemistry 348: 243–251. https://doi.org/10.1016/j.ab.2005.10.027 . (PMID: 10.1016/j.ab.2005.10.02716325757) ; Libby, P. 2002. Inflammation in atherosclerosis. Nature 420: 868–874. https://doi.org/10.1038/nature01323 . (PMID: 10.1038/nature0132312490960) ; Libby, P. 2012. Inflammation in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 32: 2045–2051. https://doi.org/10.1161/ATVBAHA.108.179705 . (PMID: 10.1161/ATVBAHA.108.179705228956653422754) ; Gaetano, G. 2001. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice. Lancet 357: 89–95. https://doi.org/10.1016/s0140-6736(00)03539-x . (PMID: 10.1016/s0140-6736(00)03539-x11197445) ; Everett, B.M., A.D. Pradhan, D.H. Solomon, N. Paynter, J. Macfadyen, E. Zaharris, M. Gupta, M. Clearfield, P. Libby, A. Hasan, R.J. Glynn, and P.M. Ridker. 2013. Rationale and design of the cardiovascular inflammation reduction trial: A test of the inflammatory hypothesis of atherothrombosis. American Heart Journal 166: 199–207. https://doi.org/10.1016/j.ahj.2013.03.018 . (PMID: 10.1016/j.ahj.2013.03.018238958013888829) ; Raber, I., C.P. McCarthy, M. Vaduganathan, D.L. Bhatt, D.A. Wood, J. Cleland, R. Blumenthal, and J.W. McEvoy. 2019. The rise and fall of aspirin in the primary prevention of cardiovascular disease. Lancet 393: 2155–2167. https://doi.org/10.1016/S0140-6736(19)30541-0 . (PMID: 10.1016/S0140-6736(19)30541-031226053) ; Gaziano, J.M., C. Broton, R. Coppolecchia, C. Cricelli, H. Darius, P.B. Gorelick, G. Howard, T.A. Pearson, P.M. Rothwell, L.M. Ruilope, M. Tendera, and G. Tognoni. 2018. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): A randomised, double-blind, placebo-controlled trial. Lancet 392: 1036–1046. https://doi.org/10.1016/S0140-6736(18)31924-X . (PMID: 10.1016/S0140-6736(18)31924-X301580697255888) ; Huang, Y., H.M. Liu, Y.X. Zhang, J. Li, C.P. Wang, L. Zhou, Y. Jia, and X.H. Li. 2017. Synthesis and biological evaluation of ginsenoside compound K derivatives as a novel class of LXRα activator. Molecules 22: 1232. https://doi.org/10.3390/molecules22071232 . (PMID: 10.3390/molecules22071232287377266152260) ; Capodanno, D., and D.J. Angiolillo. 2018. Canakinumab for secondary prevention of atherosclerotic disease. Expert Opinion on Biological Therapy 18: 215–220. https://doi.org/10.1080/14712598.2018.1420776 . (PMID: 10.1080/14712598.2018.142077629265905) ; Kawanishi, K., C. Dhar, R. Do, N. Varki, P. Gordts, and A. Varki. 2019. Human species-specific loss of CMP-N-acetylneuraminic acid hydroxylase enhances atherosclerosis via intrinsic and extrinsic mechanisms. Proceedings of the National Academy of Sciences 116: 16036–16045. https://doi.org/10.1073/pnas.1902902116 . (PMID: 10.1073/pnas.1902902116) ; Zakiev, E.R., I.A. Sobenin, V.N. Sukhorukov, V.A. Myasoedova, E.A. Ivanova, and A.N. Orekhov. Carbohydrate composition of circulating multiple-modified low-density lipoprotein. Vascular Health and Risk Management 12: 379–385. https://doi.org/10.2147/VHRM.S112948 . ; Zhang, L., T.T. Wei, Y. Li, J. Li, Y. Fan, F.Q. Huang, Y.Y. Cai, G.X. Ma, J.F. Liu, Q.Q. Chen, S.L. Wang, H.L. Li, R.N. Alolga, B.L. Liu, D.S. Zhao, J.H. Shen, X.M. Wang, W. Zhu, P. Li, and L.W. Qi. 2018. Functional metabolomics characterizes a key role for N-acetylneuraminic acid in coronary artery diseases. Circulation 137: 1374–1390. https://doi.org/10.1161/CIRCULATIONAHA.117.031139 . (PMID: 10.1161/CIRCULATIONAHA.117.03113929212895) ; Lübbers, J., E. Rodríguez, and Y. Kooyk. 2018. Modulation of immune tolerance via Siglec-sialic acid interactions. Frontiers in Immunology 9: 2807. https://doi.org/10.3389/fimmu.2018.02807 . (PMID: 10.3389/fimmu.2018.02807305814326293876) ; Gruber, S., T. Hendrikx, D. Tsiantoulas, M.O. Kozma, L. Göderle, Z. Mallat, J.L. Witztum, R.S. Sverdlov, L. Nitschke, and C.J. Binder. 2016. Sialic acid-binding immunoglobulin-like lectin G promotes atherosclerosis and liver inflammation by suppressing the protective functions of B-1 cells. Cell Reports 14: 2348–2361. https://doi.org/10.1016/j.celrep.2016.02.027 . (PMID: 10.1016/j.celrep.2016.02.02726947073) ; Schleimer, R.P., R.L. Schnaar, and B.S. Bochner. 2016. Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression. Current Opinion in Allergy and Clinical Immunology 16: 24–30. https://doi.org/10.1097/ACI.0000000000000234 . (PMID: 10.1097/ACI.0000000000000234266940374811040) ; Hsu, Y.W., F.F. Hsu, M.T. Chiang, D.L. Tsai, F.A. Li, T. Angata, P.R. Crocker, and L.Y. Chau. 2021. Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation. Journal of Biomedical Science 28: 5. https://doi.org/10.1186/s12929-020-00698-z . (PMID: 10.1186/s12929-020-00698-z333973547784283) ; Kiser, Z.M., A. Lizcano, J. Nguyen, G.L. Becker, J.D. Belcher, A.P. Varki, and G.M. Vercellotti. 2020. Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease. Blood Cells, Molecules & Diseases 81: 102399. https://doi.org/10.1016/j.bcmd.2019.102399 . (PMID: 10.1016/j.bcmd.2019.102399) ; Biadgo, B., M. Melku, S.M. Abebe, and M. Abebe. 2016. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. Diabetes Metab Syndr Obes 9: 91–99. https://doi.org/10.2147/DMSO.S97563 . (PMID: 10.2147/DMSO.S97563270421344801204) ; Su, B.Y., C.F. Tian, B.L. Gao, Y.H. Tong, X.H. Zhao, and Y. Zheng. 2016. Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome. Postgraduate Medicine 128: 805–809. https://doi.org/10.1080/00325481.2016.1243980 . (PMID: 10.1080/00325481.2016.124398027690724) ; Zhou, J.W., J.H. Wu, J.T. Zhang, T. Xu, H. Zhang, Y.H. Zhang, and S.Y. Zhang. 2015. Association of stroke clinical outcomes with coexistence of hyperglycemia and biomarkers of inflammation. Journal of Stroke and Cerebrovascular Diseases 24: 1250–1255. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.01.028 . (PMID: 10.1016/j.jstrokecerebrovasdis.2015.01.02825906929) ; Zhang, D.F., W.W. Jin, R.Q. Wu, J. Li, S.A. Park, E. Tu, P. Zanvit, J.J. Xu, O.S. Liu, A. Cain, and W.J. Chen. 2019. High glucose intake exacerbates autoimmunity through reactive-oxygen-species-mediated TGF-β cytokine activation. Immunity 51: 671–681. https://doi.org/10.1016/j.immuni.2019.08.001 . (PMID: 10.1016/j.immuni.2019.08.001314513979811990) ; Bornfeldt, K.E. 2016. Does elevated glucose promote atherosclerosis? Pros and cons. Circulation Research 119: 190–193. https://doi.org/10.1161/CIRCRESAHA.116.308873 . (PMID: 10.1161/CIRCRESAHA.116.308873273903304940114) ; Patras, K.A., A. Coady, J. Olson, S.R. Ali, S.P. RamachandraRao, S. Kumar, A. Varki, and V. Nizet. 2017. Tamm-Horsfall glycoprotein engages human Siglec-9 to modulate neutrophil activation in the urinary tract. Immunology and Cell Biology 95: 960–965. https://doi.org/10.1038/icb.2017.63 . (PMID: 10.1038/icb.2017.63288290505698129) ; Jia, Y., H.F. Yu, S.M. Fernandes, Y.D. Wei, A.G. Gil, M.G. Motari, K. Vajn, W.W. Stevens, A.T. Peters, B.S. Bochner, R.C. Kern, R.P. Schleimer, and R.L. Schnaar. 2016. Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells. Current Opinion in Allergy and Clinical Immunology 16: 24–30. https://doi.org/10.1097/ACI.0000000000000234 . (PMID: 10.1097/ACI.0000000000000234) ; Pernow, J., A. Mahdi, J. Yang, and Z. Zhou. 2019. Red blood cell dysfunction: A new player in cardiovascular disease. Cardiovascular Research 115: 1596–1605. https://doi.org/10.1093/cvr/cvz156 . (PMID: 10.1093/cvr/cvz15631198931) ; Sprague, R.S., and M.L. Ellsworth. 2012. Erythrocyte-derived ATP and perfusion distribution: Role of intracellular and intercellular communication. Microcirculation 19: 430–439. https://doi.org/10.1111/j.1549-8719.2011.00158.x . (PMID: 10.1111/j.1549-8719.2011.00158.x227757603324633) ; Sikora, J., S.N. Orlov, K. Furuya, and R. Grygorczyk. 2014. Hemolysis is a primary ATP-release mechanism in human erythrocytes. Blood 124: 2150–2157. https://doi.org/10.1182/blood-2014-05-572024 . (PMID: 10.1182/blood-2014-05-572024250971784186543) ; Salgado, M.T., Z.L. Cao, E. Nagababu, J.G. Mohanty, and J.M. Rifkind. 2015. Red blood cell membrane-facilitated release of nitrite-derived nitric oxide bioactivity. Biochemistry 54: 6712–6723. https://doi.org/10.1021/acs.biochem.5b00643 . (PMID: 10.1021/acs.biochem.5b0064326478948) ; Diederich, L., T. Suvorava, R. Sansone, T.C.S. Keller 4th, F. Barbarino, T.R. Sutton, C.M. Kramer, W. Lückstädt, B.E. Isakson, H. Gohlke, M. Feelisch, M. Kelm, and M.M. Cortese-Krott. 2018. On the effects of reactive oxygen species and nitric oxide on red blood cell deformability. Frontiers in Physiology 9: 332. https://doi.org/10.3389/fphys.2018.00332 . (PMID: 10.3389/fphys.2018.00332298675165958211) ; Mohanty, J.G., E. Nagababu, and J.M. Rifkind. 2014. Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging. Frontiers in Physiology 5: 84. https://doi.org/10.3389/fphys.2014.00084 . (PMID: 10.3389/fphys.2014.00084246167073937982) ; Zhou, Z., A. Mahdi, Y. Tratsiakovich, S. Zahorán, O. Kövamees, F. Nordin, A.E. Uribe Gonzalez, M. Alvarsson, C.G. Östenson, D.C. Andersson, U. Hedin, E. Hermesz, J.O. Lundberg, J. Yang, and J. Pernow. 2018. Erythrocytes from patients with type 2 diabetes induce endothelial dysfunction via arginase I. Journal of the American College of Cardiology 72: 769–780. https://doi.org/10.1016/j.jacc.2018.05.052 . (PMID: 10.1016/j.jacc.2018.05.05230092954) ; Gopaul, K.P., and M.A. Crook. 2006. Sialic acid: A novel marker of cardiovascular disease? Clinical Biochemistry 39: 667–681. https://doi.org/10.1016/j.clinbiochem.2006.02.010 . (PMID: 10.1016/j.clinbiochem.2006.02.01016624269) ; Zhang, C., J. Chen, Y. Liu, and D. Xu. 2019. Sialic acid metabolism as a potential therapeutic target of atherosclerosis. Lipids in Health and Disease 18: 173. https://doi.org/10.1186/s12944-019-1113-5 . (PMID: 10.1186/s12944-019-1113-5315211726745061) ; Gonzalez, P.S., J. O'Prey, S. Cardaci, V.J.A. Barthet, J.I. Sakamaki, F. Beaumatin, A. Roseweir, D.M. Gay, G. Mackay, G. Malviya, E. Kania, S. Ritchie, A.D. Baudot, B. Zunino, A. Mrowinska, C. Nixon, D. Ennis, A. Hoyle, D. Millan, et al. 2018. Mannose impairs tumour growth and enhances chemotherapy. Nature 563: 719–723. https://doi.org/10.1038/s41586-018-0729-3 . (PMID: 10.1038/s41586-018-0729-330464341) ; Wang, X.J., R.L. Liu, W.C. Zhu, H.Y. Chu, H. Yu, P. Wei, X.Y. Wu, H.W. Zhu, H. Gao, J. Liang, G.H. Li, and W.W. Yang. 2019. UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis. Nature 571: 127–131. https://doi.org/10.1038/s41586-019-1340-y . (PMID: 10.1038/s41586-019-1340-y31243371) ; Tardif, J.C., and M. Samuel. 2023. Inflammation contributes to cardiovascular risk in patients receiving statin therapy. Lancet 401 (10384): 1245–1247. https://doi.org/10.1016/S0140-6736(23)00454-3 . (PMID: 10.1016/S0140-6736(23)00454-336893776) ; Cai, T., L. Abel, O. Langford, G. Monaghan, J.K. Aronson, R.J. Stevens, S. Lay-Flurrie, C. Koshiaris, R.J. McManus, F.D.R. Hobbs, and J.P. Sheppard. 2021. Associations between statins and adverse events in primary prevention of cardiovascular disease: Systematic review with pairwise, network, and dose-response meta-analyses. BMJ 374: n1537. https://doi.org/10.1136/bmj.n1537 . (PMID: 10.1136/bmj.n1537342616278279037)
- Contributed Indexing: Keywords: atherosclerosis; erythrocytes; glucose; hyperlipidemia; inflammation; siglec-9 ligands
- Substance Nomenclature: 0 (Sialic Acid Binding Immunoglobulin-like Lectins) ; 0 (Ligands) ; IY9XDZ35W2 (Glucose) ; 0 (Siglece protein, mouse) ; 0 (Antigens, CD) ; 0 (Antigens, Differentiation, B-Lymphocyte)
- Entry Date(s): Date Created: 20240306 Date Completed: 20240506 Latest Revision: 20240531
- Update Code: 20240601
|